Centre for Military Medicine, Research and Development Department, Finnish Defense Forces, FI-00301 Helsinki, Finland; Institute of Biomedicine, Pharmacology, University of Helsinki, FI-00014 Helsinki, Finland.
Centre for Military Medicine, Research and Development Department, Finnish Defense Forces, FI-00301 Helsinki, Finland.
J Clin Virol. 2014 Jul;60(3):276-81. doi: 10.1016/j.jcv.2014.03.021. Epub 2014 Apr 13.
Viral upper respiratory tract infections occur frequently among conscripts. Probiotics have reduced viral infections in children attending day care. Limited data are available on the effects of probiotics on the nasopharyngeal presence of respiratory viruses.
To assess, whether probiotics could decrease nasopharyngeal occurrence of respiratory viruses in Finnish conscripts.
In a randomized, double-blind, placebo-controlled 90- and 150-day intervention study, 239 nasopharyngeal swab samples were collected from 192 symptomatic conscripts receiving daily chewable probiotic tablet containing Lactobacillus rhamnosus GG and Bifidobacterium animalis ssp. lactis BB-12 (46.9%) or control tablet (53.1%) on visits to a garrison's health care center due to symptoms of infection. The presence of respiratory viruses was tested by PCR-methods, and viral findings were compared between the intervention groups.
184 (76.9%) nasopharyngeal samples were positive for at least one respiratory virus. Picornaviruses were the most common viruses and were detected in 155 (84.2%) of samples. Of these, 143 (92.3%) were rhinovirus-positive and 20 (12.9%) were enterovirus-positive. The control group had 83 (64%) and the probiotic group 72 (66%) picornavirus infections (p=0.79). Monthly distribution of picornaviruses showed that there were less picornavirus findings after 3 months in the probiotic group than in the control group (p=0.0069). However, probiotics did not reduce picornavirus occurrence in other months.
Overall, probiotics did not reduce viral occurrence in symptomatic conscripts. However, probiotics decreased the presence of picornaviruses after 3 months, which may imply that probiotics play a role against viruses causing common cold. Further investigations are necessary to clarify the mechanisms involved in order to target specific probiotics on specific respiratory viruses.
新兵中经常发生病毒性上呼吸道感染。益生菌可减少日托儿童的病毒感染。关于益生菌对呼吸道病毒鼻咽部存在的影响,数据有限。
评估益生菌是否可以降低芬兰新兵鼻咽部呼吸道病毒的发生。
在一项随机、双盲、安慰剂对照的 90 天和 150 天干预研究中,从因感染症状而前往驻军医疗保健中心的 192 名有症状的应征者中收集了 239 份鼻咽拭子样本,他们每天服用含有鼠李糖乳杆菌 GG 和双歧杆菌乳亚种 BB-12 的可咀嚼益生菌片(46.9%)或对照片(53.1%)。通过 PCR 方法检测呼吸道病毒的存在,并比较干预组之间的病毒检测结果。
184 份(76.9%)鼻咽样本至少有一种呼吸道病毒呈阳性。小核糖核酸病毒是最常见的病毒,在 155 份(84.2%)样本中检测到。其中,143 份(92.3%)为鼻病毒阳性,20 份(12.9%)为肠道病毒阳性。对照组有 83 例(64%)和益生菌组有 72 例(66%)小核糖核酸病毒感染(p=0.79)。小核糖核酸病毒的月度分布显示,益生菌组在 3 个月后小核糖核酸病毒的检出率低于对照组(p=0.0069)。然而,益生菌并不能减少其他月份的小核糖核酸病毒感染。
总的来说,益生菌并不能减少症状性应征者的病毒发生。然而,益生菌在 3 个月后减少了小核糖核酸病毒的存在,这可能意味着益生菌对引起普通感冒的病毒发挥作用。为了阐明针对特定呼吸道病毒的特定益生菌的作用机制,需要进一步研究。